Status:

RECRUITING

Exploring the Possible Beneficial Impact of Non-invasive and Invasive Neuromodulation on Freezing of Gait in Parkinson's Disease During Different Ambulatory Complexities: An Electrophysiological and fMRI Study

Lead Sponsor:

China Medical University Hospital

Collaborating Sponsors:

Ministry of Science and Technology, Taiwan

Conditions:

Transcranial Direct Current Stimulation

Eligibility:

All Genders

20-90 years

Phase:

NA

Brief Summary

Freezing of gait (FOG) stands out as a devastating symptom of Parkinson's disease (PD), where patients may become momentarily glued to the ground, rendering them incapable of walking efficiently. The ...

Detailed Description

First, the investigators aim to develop an artificial intelligence algorithm for the identification and quantification of FOG episodes using Red-Green-Blue (RGB) and walkway pressure data. PD patients...

Eligibility Criteria

Inclusion

  • Patients meet the diagnosis of PD based on the established consensus criteria
  • Age above 20 years old and below 90 years
  • For MRgFUS patients: a. At least one of the 3 cardinal symptoms (akinesia, tremor, rigidity) reaches an intensity of at least 2/4. b. Parkinsonian symptoms cannot be satisfactorily controlled by optimal pharmacological treatment including L-dopa and other antiparkinsonian drugs. c. stable medication for PD ≥ 30 days.
  • DBS patients must meet Taiwan Health Insurance criteria: PD duration exceeding 5 years, positive response to levodopa (≥33% UPDRS motor score improvement), and presence of motor complications (e.g., wearing off, on-off, levodopa-related dyskinesia, or medically intractable tremor).

Exclusion

  • Congestive heart failure (Functional III or above) or advanced cancer with distant metastasis.
  • PD at Hoehn and Yahr Stage 5.
  • DBS exclusion criteria: overt dementia or major depression.

Key Trial Info

Start Date :

April 30 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2027

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06505460

Start Date

April 30 2024

End Date

July 31 2027

Last Update

August 21 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

China Medical University Hospital/Neuro Depart

Taichung, Taiwan, 40447